Press release
Rotavirus Prophylaxis Market Outlook 2024: Exclusive Report By The Business Research Company | Pfizer Inc., Johnson & Johnson, Merck & Co., Novartis AG, Sanofi SA, Astra Zeneca Pharmaceuticals LP
Rotavirus Prophylaxis Market Size
The Business Research Company offers in-depth market insights through Rotavirus Prophylaxis Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The rotavirus prophylaxis market size has grown rapidly in recent years. It will grow from $8.15 billion in 2023 to $9.05 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to vaccine access and equity, emerging rotavirus strains, r&d investments, public health preparedness.
The rotavirus prophylaxis market size is expected to see strong growth in the next few years. It will grow to $13.24 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to gastrointestinal disease burden, global expansion, vaccination programs, vaccine confidence. Major trends in the forecast period include next-generation vaccines, combination vaccines, vaccine delivery innovation, global immunization collaboration.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=13045&type=smp
Market Segmentation:
The main types of treatment for rotavirus prophylaxis are rotarix, rotavac, rotavin-m1, oral rehydration fluid and others. Rotavirus is a virus that causes severe stomach or intestinal sickness such as fever, vomiting and diarrhea. The various routes of administration are oral, parenteral and others channeled through hospital pharmacy, retail pharmacy, online pharmacy and others. The end users are hospitals, specialty clinics, home care and others.
Major Driver - Rising Vaccine Courses Powering Growth In The Rotavirus Prophylaxis Market
The increasing vaccine courses are expected to propel the growth of the rotavirus prophylaxis market going forward. A vaccine course is a specific dose of vaccine that is meant to be given to a person to produce protection from a particular disease. The vaccine course dosage stimulates the immunological response, providing excellent protection against rotavirus infection. This increased immunity minimizes the risk of diseases and improves the vaccine's overall efficacy. For instance, in January 2022, according to a report published by the United Nations International Children's Emergency Fund (UNICEF), a US-based provider of humanitarian and developmental help to children, around 5.71 million courses of RV1-5 frozen rotavirus vaccine were produced 2022, with a projected increase to 9.31 million courses by 2028. Furthermore, 5.29 million courses of RV5-2 lyophilized rotavirus vaccines were manufactured in 2022, with a projected rise to 6.13 million courses by 2028. Therefore, the increasing number of vaccines will drive the rotavirus prophylaxis market.
Competitive Landscape:
Major players in the rotavirus prophylaxis market are Pfizer Inc., Johnson & Johnson, Merck & Co., Novartis AG, Sanofi SA, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Sinovac Biotech Ltd., Astellas Pharma Inc., CSL Limited, Bharat Biotech International Limited, Daiichi Sankyo Co. Ltd., Lupin Limited, Mitsubishi Tanabe Pharma Corporation, Serum Institute of India Pvt. Ltd., Zydus Lifescience Ltd., Emergent BioSolutions Inc., Hualan Biological Engineering Inc., Biocad Biopharmaceutical Co., Bharat Serums and Vaccines Limited, Biological E Limited, PT Bio Farma, Panacea Biotec Ltd., Shanghai Institute of Biological Products (SIBP).
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/rotavirus-prophylaxis-global-market-report
Top Trend - Vaccine Development And Approvals In The Rotavirus Prophylaxis Market
Major companies operating in the rotavirus prophylaxis market are developing vaccines to meet customer requirements. Vaccine approvals involve a rigorous process that includes multiple development and testing stages. These approvals are essential in ensuring that vaccines are safe and effective for preventing this viral illness, particularly in infants and young children. For instance, in November 2022, GlaxoSmithKline plc, a UK-based pharmaceutical and biotechnology company, announced that the Food and Drug Administration (FDA) had approved an oral-dosing applicator-only presentation (liquid formulation) of ROTARIX (Rotavirus Vaccine, Live and Oral), that prevents rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4 and G9) in infants. The novel oral-dosing applicator-only presentation is entirely liquid and must not be reconstituted before use. ROTARIX lyophilized and liquid formulations are administered orally in a two-dose series, contain the same live, human-attenuated rotavirus strain and are made using comparable techniques.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Rotavirus Prophylaxis Market Characteristics
3. Rotavirus Prophylaxis Market Trends And Strategies
4. Rotavirus Prophylaxis Market - Macro Economic Scenario
5. Rotavirus Prophylaxis Market Size And Growth
…..
27. Rotavirus Prophylaxis Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rotavirus Prophylaxis Market Outlook 2024: Exclusive Report By The Business Research Company | Pfizer Inc., Johnson & Johnson, Merck & Co., Novartis AG, Sanofi SA, Astra Zeneca Pharmaceuticals LP here
News-ID: 3405461 • Views: …
More Releases from The Business Research Company
Automotive Adhesives Market 2024: Key Growth Drivers and Industry Insights
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Automotive Adhesives Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $7.49 billion In 2028 At…
Wear Parts Market Size, Growth Analysis, Trends And Forecast 2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Wear Parts Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $796.11 billion In 2028 At…
Assured Positioning, Navigation, And Timing (PNT) Market Report 2024: Market Siz …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Assured Positioning, Navigation, And Timing (PNT) Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $2.94…
Hope for Sickle Cell: Treatment Market Growth and Trends 2024-2033
The sickle cell disease treatment market size has grown rapidly in recent years. It will grow from $2.46 billion in 2023 to $2.95 billion in 2024 at a compound annual growth rate (CAGR) of 20.0%. The growth in the historic period can be attributed to disease understanding, blood transfusions, pain management, hydroxyurea therapy.
The sickle cell disease treatment market size is expected to see rapid growth in the next…
More Releases for Rotavirus
Global Rotavirus Vaccines Market Analysis by 2020-2025
Global Info Research offers a latest published report on Rotavirus Vaccines Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Rotavirus Vaccines Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/Global-Rotavirus-Vaccines_p507997.html
Market…
Global Oral Rotavirus Vaccine Market 2020 Industry Status
This report also researches and evaluates the impact of Covid-19 outbreak on the Oral Rotavirus Vaccine industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Oral Rotavirus Vaccine and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
GLOBAL INFO RESEARCH indicates that the global Oral Rotavirus Vaccine market is expected to surge at a steady rate in the coming years, as economies flourish. The…
Rotavirus Vaccine Market, Worldwide, 2030
The “Rotavirus Vaccine Market Analysis to 2030” is a specialized and in-depth study of the Rotavirus Vaccine industry with a focus on the Rotavirus Vaccine market trend. The report aims to provide an overview of the Rotavirus Vaccine market with detailed market segmentation by component, application, end-user, and geography. The Rotavirus Vaccine market is expected to witness high growth during the forecast period. The report includes key statistics on the…
Rotavirus Infections Global Market Research Report 2025
Rotavirus Infections Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).
Access more details about this report at: https://www.research2reports.com/report-medical-devices/rotavirus-infections-market/81019
The report firstly introduced the Rotavirus Infections basics: definitions, classifications, applications and market…
Rotavirus Infections Therapeutics Market Future Opportunities 2017-2025
Rotavirus infections cause vomiting and diarrhea that leads to severe dehydration. Despite widespread cell death and tissue damage, the inflammatory reaction is quite limited. Rotavirus is the major cause of acute gastroenteritis in young children globally, and accounts for 600,000 child deaths each year, with the majority of deaths occurring in Middle East & Africa and Asia Pacific. The primary clinical symptoms of rotavirus infections are severe vomiting and diarrhea,…
Rotavirus Diagnostics Market – Stratergies, Growth, Latest Trend & Forecast 20 …
Rotavirus is a major cause of severe childhood gastroenteritis. Rotavirus, the most significant member of the Reoviridae family, is responsible for almost two million hospital admissions, around 25 million clinic visits, and more than 0.8 million deaths among children below the age of five globally each year. Rotavirus has a worldwide incidence, both in developed and developing countries; however, maximum deaths have been observed in the developing countries. It is…
